Regulation of Epstein-Barr virus gene expression via CRISPR-mediated targeting of DNA methylation enzymes
Epstein-Barr virus (EBV) can establish an oncogenic presence in cells to cause transformation. Globally, EBV drives a number of human cancers, including Natural Killer/T cell Lymphoma (NKTL). NKTL is an aggressive malignancy thought to express a limited number of EBV proteins, namely EBV nuclear...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/176099 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Epstein-Barr virus (EBV) can establish an oncogenic presence in cells to cause
transformation. Globally, EBV drives a number of human cancers, including Natural
Killer/T cell Lymphoma (NKTL). NKTL is an aggressive malignancy thought to
express a limited number of EBV proteins, namely EBV nuclear antigen 1 (EBNA1)
and latent membrane proteins (LMPs) 1 and 2. However, apart from these, NKTLs
also express a wide range of EBV transcripts that do not appear to be translated.
LMP1 transcript levels have been positively correlated whereas late lytic gene levels
are negatively correlated with patient survival. The regulation of LMP1 and lytic gene
expression is not fully understood. Therefore, in this study, the role of DNA
methylation enzymes, DNMT1, DNMT3A and UHRF1, in regulating LMP1, BZLF1
and BRRF2 were clarified. Additionally, LMP1 was investigated for its regulation on
these genes. Through gene editing and expression analyses, DNMT1, UHRF1,
DNMT3A downregulate LMP1 expression. Intriguingly, while DNMT3A
downregulated lytic genes, DNMT1 and UHRF1 upregulated BZLF1 and BRRF2,
contrary to current understanding. Furthermore, LMP1 influences both latency and
lytic gene expression. Thus, DNMT1, DNMT3A, UHRF1 and LMP1 could be
potential targets in increasing immunogenicity in NKTL in order to enhance immune
clearance of tumour mass. |
---|